Literature DB >> 10772626

Regulation of the CYP3A4 gene by hydrocortisone and xenobiotics: role of the glucocorticoid and pregnane X receptors.

W El-Sankary1, N J Plant, G G Gibson, D J Moore.   

Abstract

The molecular mechanisms of regulation of the CYP3A4 gene have been examined in an in vitro reporter gene system, containing -1 kb of the CYP3A4 promoter, in a HepG2 cell line. This system allows for the separate and combined transfection of expression plasmids encoding the human glucocorticoid receptor (hGR) and the human pregnane X receptor (hPXR), and, therefore, the opportunity to assess the role of these receptors in the induction process. Hydrocortisone produces a dose-dependent increase in CYP3A4 activation, a response that is increased in the presence of either receptor. Moreover, transfection of the hPXR decreased the EC(50) for hydrocortisone-dependent induction by a factor of 3.3, a response that was not changed by simultaneous cotransfection of the hGR. In addition, the hydrocortisone dose-response curve falls within the physiological blood level concentration of this steroid, implicating a regulatory role for hydrocortisone in the basal level of CYP3A4 expression. Although the responses to dexamethasone and rifampicin were both increased by both receptors, dexamethasone activation of CYP3A4 was similar for both the hGR and the hPXR, whereas rifampicin-dependent activation favored the hPXR. We conclude that regulation of the CYP3A4 gene is receptor-dependent and that hydrocortisone may function as a regulator of basal expression via the hPXR and the hGR. The implications of this latter conclusion for possible regulatory interactions between hydrocortisone and xenobiotic inducers remain to be clarified.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772626

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  13 in total

1.  Dosing equation for tacrolimus using genetic variants and clinical factors.

Authors:  Chaitali Passey; Angela K Birnbaum; Richard C Brundage; William S Oetting; Ajay K Israni; Pamala A Jacobson
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

2.  Hypoxia-induced down-regulation of CYP1A1/1A2 and up-regulation of CYP3A6 involves serum mediators.

Authors:  Caroline Fradette; Anne-Marie Bleau; Vincent Pichette; Nathalie Chauret; Patrick Du Souich
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

3.  The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation.

Authors:  P Stratta; M Quaglia; T Cena; R Antoniotti; R Fenoglio; A Menegotto; D Ferrante; A Genazzani; S Terrazzino; C Magnani
Journal:  Eur J Clin Pharmacol       Date:  2011-11-20       Impact factor: 2.953

4.  Effect of danshen extract on the activity of CYP3A4 in healthy volunteers.

Authors:  Furong Qiu; Guangji Wang; Rong Zhang; Jianguo Sun; Jian Jiang; Yueming Ma
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

5.  Mechanisms of CYP3A Induction During Pregnancy: Studies in HepaRG Cells.

Authors:  Madhav Sachar; Edward J Kelly; Jashvant D Unadkat
Journal:  AAPS J       Date:  2019-03-27       Impact factor: 4.009

6.  Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.

Authors:  Andrew Owen; Chris Goldring; Paul Morgan; David Chadwick; B Kevin Park; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

7.  Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.

Authors:  Masatomo Miura; Shigeru Satoh; Kazuyuki Inoue; Hideaki Kagaya; Mitsuru Saito; Takamitsu Inoue; Toshio Suzuki; Tomonori Habuchi
Journal:  Eur J Clin Pharmacol       Date:  2007-09-29       Impact factor: 2.953

8.  Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China.

Authors:  Xiang-guang Meng; Cheng-xian Guo; Guo-qing Feng; Ying-chun Zhao; Bo-Ting Zhou; Jian-le Han; Xin Chen; Yong Shi; Hong-yao Shi; Ji-ye Yin; Xiang-dong Peng; Qi Pei; Wei Zhang; Guo Wang; Meng He; Min Liu; Jing-ke Yang; Hong-hao Zhou
Journal:  Acta Pharmacol Sin       Date:  2012-10-22       Impact factor: 6.150

9.  Tacrolimus Dose-Conversion Ratios Based on Switching of Formulations for Patients with Solid Organ Transplants.

Authors:  Wen-Yuan Johnson Kuan; Nathalie Châteauvert; Vincent Leclerc; Benoît Drolet
Journal:  Can J Hosp Pharm       Date:  2021

10.  Optimization of stress response through the nuclear receptor-mediated cortisol signalling network.

Authors:  Alexey Kolodkin; Nilgun Sahin; Anna Phillips; Steve R Hood; Frank J Bruggeman; Hans V Westerhoff; Nick Plant
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.